Mohyadini, M., Fahimi, A., Bathaie, S. Z., & Yaghooti, H. Ranolazine as a therapeutic agent for diabetic cardiomyopathy: Reducing endoplasmic reticulum stress and inflammation in type 2 diabetic rat model. BMC.
Chicago Style (17th ed.) CitationMohyadini, Matin, Aghele Fahimi, S. Zahra Bathaie, and Hamid Yaghooti. Ranolazine as a Therapeutic Agent for Diabetic Cardiomyopathy: Reducing Endoplasmic Reticulum Stress and Inflammation in Type 2 Diabetic Rat Model. BMC.
MLA (9th ed.) CitationMohyadini, Matin, et al. Ranolazine as a Therapeutic Agent for Diabetic Cardiomyopathy: Reducing Endoplasmic Reticulum Stress and Inflammation in Type 2 Diabetic Rat Model. BMC.
Warning: These citations may not always be 100% accurate.